838. Deputy Albert Dolan asked the Minister for Health whether she is satisfied that current reimbursement timelines for orphan medicines align with the commitments on timely and equitable access set out in the National Rare Disease Strategy 2025–2030; the measures that are being taken to address delays in cases where EMA-approved treatments, including those for Friedreich’s ataxia, remain unavailable to patients in Ireland; and if she will make a statement on the matter. [31882/26]

Summary

838. Deputy Albert Dolan asked the Minister for Health whether she is satisfied that current reimbursement timelines for orphan medicines align with the commitments on timely and equitable access set out in the National Rare Disease Strategy 2025–2030; the measures that are being taken to address delays in cases where EMA-approved treatments, including those for Friedreich’s ataxia, remain unavailable to patients in Ireland; and if she will make a statement on the matter. [31882/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 6 May 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.